|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
a Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu, Japan;
b Division of Gastroenterology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA
Key Words. Liver cancer • MDR1 • BCRP1 • Microarray • Chemosensitivity assay • Invasion assay
Correspondence: Masaki Mori, M.D., Ph.D., Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Tsurumihara 4546, Beppu 874-0838, Japan. Telephone: +81-977-27-1650; Fax: +81-977-27-1651; e-mail: mmori{at}tsurumi.beppu.kyushu-u.ac.jp
Received on June 24, 2005;
accepted for publication on October 13, 2005.
A subset of stem cells, termed "side population" (SP) cells, has been identified and characterized in several mammalian tissues and cell lines. However, SP cells have never been identified or isolated from gastrointestinal cancers. We used flow cytometry and the DNA-binding dye Hoechst 33342 to isolate SP cells from various human gastrointestinal system cancer cell lines. Fifteen of sixteen cancer cell lines from the gastrointestinal system contained 0.3%2.2% SP cells. Next, we used an oligonucleotide microarray to analyze differentially expressed genes between SP and non-SP cells of hepatoma HuH7. The expression of GATA6, which is associated with embryonic development and hepatocytic differentiation, was significantly upregulated in HuH7 SP cells. The expression of ABCG2, ABCB1, and CEACAM6, which are associated with chemoresistance, was also significantly increased in SP cells. In addition, some epithelial markers and mesenchymal markers were overexpressed in SP cells. Reverse transcription-polymerase chain reaction and immunocytochemical staining validated these results and suggested a multilineage potential for HuH7 SP cells. In hepatoma HuH7 and colorectal SW480 cell lines, SP cells showed evidence for self-renewal, generating both SP and non-SP cells. Finally, chemoresistance to anticancer agents, including doxorubicin, 5-fluorouracil, and gemcitabine, were compared between HuH7 SP and non-SP cells using an ATP bioluminescence assay. The HuH7 SP cells expressed a higher resistance to doxorubicin, 5-fluorouracil, and gemcitabine compared with non-SP cells. These findings demonstrate that cancers of the gastrointestinal system do contain SP cells that show some characteristics of so-called stem cells.
This article has been cited by other articles:
![]() |
T. Tanei, K. Morimoto, K. Shimazu, S. J. Kim, Y. Tanji, T. Taguchi, Y. Tamaki, and S. Noguchi Association of Breast Cancer Stem Cells Identified by Aldehyde Dehydrogenase 1 Expression with Resistance to Sequential Paclitaxel and Epirubicin-Based Chemotherapy for Breast Cancers Clin. Cancer Res., June 15, 2009; 15(12): 4234 - 4241. [Abstract] [Full Text] [PDF] |
||||
![]() |
Hongling Du and H. S. Taylor Reviews: Stem Cells and Female Reproduction Reproductive Sciences, February 1, 2009; 16(2): 126 - 139. [Abstract] [PDF] |
||||
![]() |
C. Hu, H. Li, J. Li, Z. Zhu, S. Yin, X. Hao, M. Yao, S. Zheng, and J. Gu Analysis of ABCG2 expression and side population identifies intrinsic drug efflux in the HCC cell line MHCC-97L and its modulation by Akt signaling Carcinogenesis, December 1, 2008; 29(12): 2289 - 2297. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Chiba, S. Miyagi, A. Saraya, R. Aoki, A. Seki, Y. Morita, Y. Yonemitsu, O. Yokosuka, H. Taniguchi, H. Nakauchi, et al. The Polycomb Gene Product BMI1 Contributes to the Maintenance of Tumor-Initiating Side Population Cells in Hepatocellular Carcinoma Cancer Res., October 1, 2008; 68(19): 7742 - 7749. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Tilly and B. R. Rueda Stem Cell Contribution to Ovarian Development, Function, and Disease Endocrinology, September 1, 2008; 149(9): 4307 - 4311. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Szotek, H. L. Chang, K. Brennand, A. Fujino, R. Pieretti-Vanmarcke, C. Lo Celso, D. Dombkowski, F. Preffer, K. S. Cohen, J. Teixeira, et al. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics PNAS, August 26, 2008; 105(34): 12469 - 12473. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Moserle, S. Indraccolo, M. Ghisi, C. Frasson, E. Fortunato, S. Canevari, S. Miotti, V. Tosello, R. Zamarchi, A. Corradin, et al. The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-{alpha} Antitumor Effects Cancer Res., July 15, 2008; 68(14): 5658 - 5668. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Das, R. Tsuchida, D. Malkin, G. Koren, S. Baruchel, and H. Yeger Hypoxia Enhances Tumor Stemness by Increasing the Invasive and Tumorigenic Side Population Fraction Stem Cells, July 1, 2008; 26(7): 1818 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhang, R. Komaki, L. Wang, B. Fang, and J. Y. Chang Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic Adenovirus Clin. Cancer Res., May 1, 2008; 14(9): 2813 - 2823. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. D. Lichtenauer, I. Shapiro, K. Geiger, M. Quinkler, M. Fassnacht, R. Nitschke, K.-D. Ruckauer, and F. Beuschlein Side Population Does Not Define Stem Cell-Like Cancer Cells in the Adrenocortical Carcinoma Cell Line NCI h295R Endocrinology, March 1, 2008; 149(3): 1314 - 1322. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ieta, F. Tanaka, N. Haraguchi, Y. Kita, H. Sakashita, K. Mimori, T. Matsumoto, H. Inoue, H. Kuwano, and M. Mori Biological and Genetic Characteristics of Tumor-Initiating Cells in Colon Cancer Ann. Surg. Oncol., February 1, 2008; 15(2): 638 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Hill and R. Perris "Destemming" Cancer Stem Cells J Natl Cancer Inst, October 3, 2007; 99(19): 1435 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zen, T. Fujii, S. Yoshikawa, H. Takamura, T. Tani, T. Ohta, and Y. Nakanuma Histological and Culture Studies with Respect to ABCG2 Expression Support the Existence of a Cancer Cell Hierarchy in Human Hepatocellular Carcinoma Am. J. Pathol., May 1, 2007; 170(5): 1750 - 1762. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Szotek, H. L. Chang, L. Zhang, F. Preffer, D. Dombkowski, P. K. Donahoe, and J. Teixeira Adult Mouse Myometrial Label-Retaining Cells Divide in Response to Gonadotropin Stimulation Stem Cells, May 1, 2007; 25(5): 1317 - 1325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, L.-P. Guo, L.-Z. Chen, Y.-X. Zeng, and S. H. Lu Identification of Cancer Stem Cell-Like Side Population Cells in Human Nasopharyngeal Carcinoma Cell Line Cancer Res., April 15, 2007; 67(8): 3716 - 3724. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, M. R. Baer, M. J. Bowman, P. Pera, X. Zheng, J. Morgan, R. A. Pandey, and A. R. Oseroff The Tyrosine Kinase Inhibitor Imatinib Mesylate Enhances the Efficacy of Photodynamic Therapy by Inhibiting ABCG2 Clin. Cancer Res., April 15, 2007; 13(8): 2463 - 2470. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ishikawa, A. Sasaki, N. Haraguchi, Y. Yoshikawa, and M. Mori A Case of an {alpha}-Fetoprotein-Producing Intrahepatic Cholangiocarcinoma Suggests Probable Cancer Stem Cell Origin Oncologist, March 1, 2007; 12(3): 320 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Kruger, C. D. Kaplan, Y. Luo, H. Zhou, D. Markowitz, R. Xiang, and R. A. Reisfeld Characterization of stem cell-like cancer cells in immune-competent mice Blood, December 1, 2006; 108(12): 3906 - 3912. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Morita, H. Ema, S. Yamazaki, and H. Nakauchi Non-side-population hematopoietic stem cells in mouse bone marrow Blood, October 15, 2006; 108(8): 2850 - 2856. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |